Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
Conditions
Interventions
None listed
Sponsors
Dr Snehal Namdev Kakade
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients who will give informed written consent for study. 2 Patients of age group 18 to 49 years (reproductive age group). 3 The patients having clinical signs and symptoms of Raktapradara - Raja Ati Pravrutti (Excessive menstrual bleeding), Dirgha Kala Artava Pravrutti (Prolong menstrual bleeding more than 7 days), Vedana in Shroni Prushtha and Kukshi (Pain in the pelvic region), Yonigat Daha (Burning sensation in external genitalia), Daurbalya (Generalized Weakness), Angmard (Bodyache). 4 Hemoglobin percentage above 7 g/dl.
Exclusion criteria
Exclusion criteria: 1 K/C/O pelvic and uterine pathology like Uterine fibroid, Polyp, Pelvic inflammatory disease, Adenomyosis, Post-menopausal bleeding,malignant and non- malignant tumors. 2 K/C/O Any significant chronic illness. 3 K/C/O ectopic pregnancy, recent abortion, DUB. 4 K/C/O any external injury to reproductive track. Patients with IUCD and OCP pills. Patients taking Anti-coagulation therapy and having any coagulant defects like Thrombocytopenic Purpura.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in sign and symptoms of raktapradar such as raja aati pravrutti, Dirgha kala artava pravrutti, vedana in shroni, prushtha,kakshi,yonigat daha.Timepoint: Duration of study- 18 months Duration of treatment- 12 weeks Follow up - 2nd, 4th week of 3 consecutive menstrual cycles(12weeks). | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Mangesh Moule
SST Ayurved mahavidyalay, Sangamner
Outcome results
None listed